Landmark biomechanical study shows AxioMed's viscoelastic lumbar disc is the first implant to replicate the natural ...

The increasing geriatric demographic in the U.S. continues to be a primary contributor to market growth, as elderly patients ...

In accordance with standard industry practice, BioRestorative plans to wait to provide investors with further updates on the Type B meeting until such time that it has received and reviewed the ...

The spine is vital for movement and support. Disorders like disc herniation and scoliosis cause pain and stiffness. These ...

The future of spine pain care and pain management is increasingly interventional, collaborative, and outcome-driven.

November 07, 2025 – PRESSADVANTAGE – North American Spine and Pain has announced the introduction of a new clinical approach ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months ...

The Synergy disc was statistically superior to anterior cervical discectomy and fusion after two years, according to a U.S. investigational device exemption study. Five things to know: 1. The ...

FDA has designated rexlemestrocel-L a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of chronic low back pain. RMAT designation provides all the benefits of Breakthrough and Fast ...

MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S.

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...